FROM THE STONE AGE TO THE STATE OF THE ART – MULTIDIMENSIONAL PRECISION MEDICINE FOR PERITONEAL CRC

Grant number: 1156391 | Funding period: 2019 - 2023

Active

Abstract

Peritoneal cancer develops in the abdomen and may be present at primary diagnosis but can also arise from tumour cells that remain post-surgery or indeed they are mobilized by surgery. It is extremely difficult and expensive to treat and is rapidly fatal compared to most other cancers. We will use genetics, immunology assays, pre-clinical models with national and international collaborations to reduce, treat and cure peritoneal cancer and will test whether we can change clinical practice.

Related publications (5)

Scholarly works icon

ASO Author Reflections: Humidification of Carbon Dioxide for Insufflation Offers Promise in Reducing Inflammation and Peritoneal Trauma During and Post Colorectal Cancer Surgery

Robert Ramsay, Shienny Sampurno, Michael P Flood, Andrew C Lynch

2023-01-02

Scholarly works icon

New insights into the unique nature of colorectal cancer peritoneal metastases-rethinking HIPEC

Robert G Ramsay, Michael Flood

2022-07-13

Colorectal peritoneal metastases (CRPM) can be resistant to the chemotherapy agent (oxaliplatin) most employed, up until recently,..

Scholarly works icon

Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery: A Randomized Controlled Trial

Shienny Sampurno, Timothy Chittleborough, Meara Dean, Michael Flood, Sandra Carpinteri, Sara Roth, Rosemary M Millen, Helen Cain, Joseph CH Kong, John MacKay, Satish K Warrier, Jacob McCormick, Jonathon G Hiller, Alexander G Heriot, Robert G Ramsay, Andrew C Lynch

2022-07-06

BACKGROUND: Pre-clinical studies indicate that dry-cold-carbon-dioxide (DC-CO2) insufflation leads to more peritoneal damage, infl..

Scholarly works icon

Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review

Michael Flood, Vignesh Narasimhan, Kasmira Wilson, Wei Mou Lim, Robert Ramsay, Michael Michael, Alexander Heriot

2021-10-01

BACKGROUND: Patients with locally advanced or metastatic colorectal cancer (CRC) display heterogeneous responses to standard-of-ca..

Scholarly works icon

Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy

Vignesh Narasimhan, Josephine A Wright, Michael Churchill, Tongtong Wang, Rachele Rosati, Tamsin RM Lannagan, Laura Vrbanac, Anne B Richardson, Hiroki Kobayashi, Timothy Price, Gayle XY Tye, Julie Marker, Peter J Hewett, Michael P Flood, Shalini Pereira, G Adam Whitney, Michael Michael, Jeanne Tie, Siddhartha Mukherjee, Carla Grandori

2020-07-15

PURPOSE: Patients with colorectal cancer with peritoneal metastases (CRPMs) have limited treatment options and the lowest colorect..